Perimenopause, Menopause, and Bioidentical HRT: What You Need to Know

For generations, women have been told that the symptoms of perimenopause and menopause are simply part of getting older. Something to manage. Something to endure. Hot flashes, poor sleep, brain fog, mood swings, weight gain, low libido, vaginal dryness, joint pain. Just part of the deal.

That framing is wrong, and it has done a lot of harm. These symptoms are not a character flaw or an inevitable consequence of aging. They are the direct result of a hormone deficiency. And like most hormone deficiencies, they can be treated safely and effectively when approached correctly.

The goal of this post is to explain what’s actually happening hormonally during perimenopause and menopause, address the fears that keep many women from seeking treatment, and explain what a comprehensive, individualized hormone program at Staywell Health actually looks like.

What’s Actually Happening

Perimenopause is the transition period leading up to menopause, typically beginning in the early to mid-40s, though it can start as early as the mid-30s. During this time, the ovaries begin producing less estrogen and progesterone, but the decline is erratic rather than gradual. Hormone levels fluctuate widely, sometimes surging and sometimes plummeting, which is why perimenopause symptoms can feel so unpredictable and confusing. You can have a perfectly normal period one month and skip the next. You can feel fine for a week and then be hit by hot flashes and insomnia out of nowhere.

Menopause itself is defined as twelve consecutive months without a menstrual period. At that point, the ovaries have largely stopped producing estrogen and progesterone, and the body has to adapt to functioning with a fraction of the hormones it relied on for decades. Postmenopause is everything after that transition.

Testosterone, which most people associate exclusively with men, is also produced by the ovaries and adrenal glands in women, and it declines significantly during and after menopause. Low testosterone in women contributes to fatigue, low libido, loss of muscle mass, cognitive changes, and mood instability, and it is one of the most overlooked pieces of the hormonal puzzle in women’s health.

Symptoms Most Women Don’t Connect to Hormones

The well-known symptoms of perimenopause and menopause, hot flashes and night sweats, get most of the attention. But the list of symptoms driven by hormone decline is far longer than most women realize, and many are misattributed to stress, depression, thyroid problems, or just "getting older."

• Brain fog and memory lapses. Estrogen plays a direct role in cognitive function, neuronal signaling, and memory. The brain fog of perimenopause is real, measurable, and driven by estrogen fluctuation.
• Anxiety and mood changes. Progesterone has a calming, GABA-like effect on the nervous system. When it drops, anxiety, irritability, and mood instability often follow. Many women are prescribed antidepressants or anti-anxiety medications during perimenopause when what they actually need is progesterone.
• Sleep disruption. Both estrogen and progesterone support healthy sleep architecture. Their decline disrupts sleep quality even when night sweats aren’t present. Progesterone in particular has a sedative quality that helps with sleep onset and maintenance.
• Joint pain and stiffness. Estrogen has anti-inflammatory properties throughout the body. Its decline is associated with increased joint pain and stiffness, particularly in the hands, knees, and hips.
• Heart palpitations. Estrogen influences the cardiovascular system including heart rate regulation. Palpitations during perimenopause are common and often alarming, but frequently hormonal in origin.
• Weight gain, particularly around the midsection. Hormonal shifts during menopause change where the body stores fat and how efficiently it metabolizes it. This is not simply a matter of eating more or moving less.
• Hair thinning and skin changes. Estrogen supports collagen production and skin thickness. Its decline accelerates both hair thinning and skin aging.
• Urinary symptoms. The tissues of the bladder and urethra are estrogen-dependent. Low estrogen contributes to urinary urgency, frequency, and recurrent UTIs, a condition called genitourinary syndrome of menopause.

The Fear Around HRT: Setting the Record Straight

In 2002, the Women’s Health Initiative (WHI) published a study that sent shockwaves through medicine and caused millions of women to stop hormone therapy overnight. The study reported increased risks of breast cancer, heart disease, stroke, and blood clots in women taking HRT. Providers stopped prescribing it. Women stopped asking for it. And a generation of women suffered through menopause without treatment because the risk message became all-consuming.

What got lost in the panic was a critical detail: the WHI studied synthetic hormones, specifically conjugated equine estrogen derived from horse urine and synthetic progestin (medroxyprogesterone acetate), not bioidentical hormones. It also studied older women, average age 63, who were well past menopause, not women in perimenopause or early menopause. And subsequent reanalysis of the data showed that the increased breast cancer risk was primarily associated with the synthetic progestin, not the estrogen.

The medical community has substantially revised its understanding of HRT since 2002. Current evidence, including reanalysis of WHI data and numerous subsequent studies, shows that bioidentical hormone therapy initiated within ten years of menopause onset, often called the "timing hypothesis" or the "window of opportunity," is associated with reduced cardiovascular risk, reduced risk of cognitive decline, improved bone density, and better quality of life, with a significantly more favorable risk profile than the synthetic hormones studied in WHI.

Bioidentical hormones are chemically identical to what your body produces. They are not the same as the synthetic hormones that drove the original concerns. This distinction matters enormously and is one that conventional medicine has been slow to communicate clearly to patients.

The Three Core Hormones

Estrogen

Estrogen is the primary female sex hormone and one of the most biologically active compounds in the body. It influences over 400 functions, including cardiovascular health, bone density, cognitive function, skin integrity, mood, sleep, and metabolic rate. The primary form used in bioidentical HRT is estradiol, the same form the ovaries produce. It is available as a transdermal cream, patch, or gel, or as a vaginal preparation for genitourinary symptoms. Oral estrogen is generally avoided in bioidentical programs because it passes through the liver and has a different metabolic profile than transdermal estrogen.

Progesterone

Progesterone is often called the "calming hormone" for its sedative, anti-anxiety effects on the nervous system. It balances estrogen, supports sleep, reduces inflammation, and protects the uterine lining. In women with a uterus, progesterone must be used alongside estrogen to prevent endometrial overgrowth. Bioidentical progesterone (Prometrium or compounded progesterone) is distinct from synthetic progestin, and the two have meaningfully different effects in the body. Bioidentical progesterone does not carry the same breast cancer association that synthetic progestin does in the research.

Testosterone

Women need testosterone too, just in smaller amounts than men. Testosterone in women supports libido, energy, muscle maintenance, cognitive sharpness, and mood. After menopause, testosterone levels can drop by 50% or more. Low-dose testosterone therapy in women is one of the most effective interventions for low libido and fatigue, and it has a good safety profile when used appropriately. It is typically delivered as a compounded topical cream. This is an area that remains underutilized in conventional women’s healthcare, and it makes a meaningful difference for many patients.

Additional Hormones and Adjunctive Support

DHEA

DHEA is an adrenal hormone that serves as a precursor to both estrogen and testosterone. It declines with age and its decline contributes to fatigue, low mood, and reduced sexual function. Vaginal DHEA (prasterone) has FDA approval for treating painful intercourse associated with menopause and is a useful option for genitourinary symptoms. Systemic DHEA can also be used as part of a broader hormone optimization program when levels are low.

Pregnenolone

Pregnenolone is the upstream precursor to virtually all steroid hormones including estrogen, progesterone, testosterone, DHEA, and cortisol. It also has direct neurosteroid effects, supporting cognitive function, mood, and memory. Low pregnenolone can contribute to brain fog and anxiety that doesn’t fully resolve with estrogen and progesterone alone. We check it as part of a comprehensive panel and address it when indicated.

The Thyroid and Adrenal Connection

This is important and often overlooked. Thyroid dysfunction and adrenal dysregulation frequently co-occur with perimenopause and can amplify every symptom on the list. Hypothyroidism causes fatigue, weight gain, brain fog, depression, and cold intolerance. It can look almost identical to perimenopause, and the two commonly occur together. Chronic stress and adrenal fatigue drive cortisol dysregulation, which disrupts sleep, promotes belly fat, worsens anxiety, and interferes with sex hormone production. A hormone program that addresses only estrogen, progesterone, and testosterone while ignoring thyroid and adrenal function is incomplete. At Staywell Health, we evaluate all of these systems together rather than in isolation.

Sexual Health and Libido

Low libido is one of the most common and least discussed symptoms of hormonal decline in women. It is driven by multiple factors simultaneously: falling testosterone, declining estrogen causing vaginal dryness and discomfort, progesterone imbalance affecting mood and energy, and the psychological weight of not feeling like yourself for months or years. Treating it requires addressing the full hormonal picture rather than any single variable.

Vaginal estrogen is one of the most effective and safest interventions for genitourinary symptoms, including dryness, discomfort with intercourse, and urinary symptoms. It is applied locally, is minimally absorbed systemically, and is considered safe even for women who may not be candidates for systemic hormone therapy. It is dramatically underused relative to how many women are suffering from symptoms it would address.

For women where low libido persists despite optimized hormone levels, PT-141 (bremelanotide) is an option worth discussing. As we covered in last month’s men’s health post, PT-141 works centrally in the brain to increase sexual desire rather than acting on blood flow. It has FDA approval specifically for hypoactive sexual desire disorder in premenopausal women and is used off-label in postmenopausal women as well.

What a Program at Staywell Health Looks Like

We start with a thorough history and a comprehensive lab panel. Not just estrogen and progesterone, but also testosterone, free testosterone, SHBG, DHEA-S, pregnenolone, FSH, LH, thyroid function including T3 and T4, cortisol, and metabolic markers. This gives us a complete picture of where you are hormonally before we make any recommendations.

From there, we build an individualized program. Delivery method, dosing, and the combination of hormones used are all tailored to your labs, your symptoms, your history, and your goals. We monitor regularly and adjust as your body responds. Hormone optimization is not a one-size-fits-all prescription. It is an ongoing, collaborative process.

The goal is not to make you feel artificially young. It is to restore your hormones to levels where your body functions well, where your symptoms resolve, and where you feel like yourself again. For many women, that is genuinely life-changing.